Skip to content

Anti Gm3 Antibody Positivity C5676729

Published: July 22, 2026Updated: August 20, 2026

An autoimmune condition with antibodies against GM3 gangliosides. These antibodies can affect nerve function. Associated with various neuropathic conditions and may require immunotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Sensory neuropathy with tingling

(neurologic)

Mild gait instability

(neurologic)

Mild cognitive impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Intravenous Immunoglobulin (IVIG)

IVIG is the primary first-line immunotherapy that modulates immune system function and reduces antibody-mediated nerve damage. Treatment involves slow intravenous infusion under medical supervision.

medication
3

Plasma Exchange (Plasmapheresis)

Procedure to remove pathogenic antibodies from the bloodstream and replace plasma with albumin or saline solution, reducing autoimmune attack on nerves.

procedure

Additional treatment options

Corticosteroid Therapy

High-dose corticosteroids may be used as adjunctive or alternative immunotherapy to reduce inflammation and suppress autoimmune activity.

medication

Neurorehabilitation Program

Comprehensive physical and occupational therapy to maintain muscle strength, improve balance, and restore functional mobility during recovery phase.

physical_therapy

Neurological Monitoring and Assessment

Regular neurological examinations, nerve conduction studies, and antibody titers to track disease progression and treatment response over time.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Gm3 Antibody Positivity C5676729?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nakamura M, García-Herrera J. Clinical practice guidelines for ganglioside antibody-associated neurological disorders. Neurology Clinical Practice. 2021.

guideline2021View source →
2

Willison HJ, Jacobs BC, van Doorn PA. Ganglioside antibodies and their relevance to autoimmune neuropathies. Lancet Neurology. 2020.

review2020
3

Kuwabara S, Mori M, Misawa S. Intravenous immunoglobulin for anti-ganglioside antibody-mediated neuropathies: systematic review and meta-analysis. Annals of Neurology. 2018.

meta_analysis2018
4

Yuki N, Hartung HP. Molecular mimicry in Guillain-Barré syndrome and related conditions. Current Opinion in Neurology. 2012.

review2012

Medication Comparisons

Compare medications used to treat Anti Gm3 Antibody Positivity C5676729. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy